← Eichor
Condition: Safety Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Safety

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency
Phase 4 · 1 location(s) · Prove pharm · NCT06054880A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Can
Phase 3 · 49 location(s) · Dizal (Jiangsu) Pharmaceutical Co., Ltd. · NCT07182682UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06245746Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)
Phase 2 · 1 location(s) · National and Kapodistrian University of Athens · NCT07584083Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07043894A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
Phase 2 · 44 location(s) · Ipsen · NCT06937931A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Phase 3 · 42 location(s) · Cascade Pharmaceuticals, Inc · NCT07282353APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST
Phase 1 · 1 location(s) · Ascentage Pharma Group Inc. · NCT06687070PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients
Phase 2 · 1 location(s) · Fudan University · NCT06359275Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosome Intranasal Instillations for St
Phase 1 · 2 location(s) · The Foundation for Orthopaedics and Regenerative Medicine · NCT05158101Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS
Phase 1 · 2 location(s) · HTIC, Inc · NCT07449572A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcom
Phase 1/Phase 2 · 6 location(s) · GlaxoSmithKline · NCT07602777A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
Phase N/A · 6 location(s) · Genetix Biotherapeutics Inc. · NCT06271512A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Phase 3 · 174 location(s) · Pfizer · NCT07282665Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT04231565The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Laparoscopic Surgery
NA · 1 location(s) · Beijing Tiantan Hospital · NCT07458256Proof of Concept Study on BP1.4979 Effect on Essential Tremor
Phase 2 · 14 location(s) · Bioprojet · NCT07074002Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.
Phase 2 · 12 location(s) · Alphyn Biologics · NCT06855745Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents
Phase 3 · 1 location(s) · CUTISS AG · NCT06745557Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer
Phase 3 · 2 location(s) · Shanghai Yizhong Pharmaceutical Co., Ltd. · NCT06752811A Prospective, Multicenter, Single-arm Study to Evaluate a Transcatheter Aortic Valve System Safety and Efficacy for the
NA · 1 location(s) · Pan Xiangbin · NCT06136429A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices
Phase N/A · 3 location(s) · Teleflex · NCT06604039Evaluation of Performance and Safety of INNEA and INNEA AQUA for the Treatment of Cheek and décolletage Wrinkles
NA · 3 location(s) · Innate srl · NCT07331181SABER Study for Selected Early Stage Breast Cancer
NA · 1 location(s) · University of Miami · NCT04360330Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
NA · 1 location(s) · University of Massachusetts, Worcester · NCT06223867Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk R
Phase 2 · 4 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07239245Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05126472Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.
Phase 1 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT04778839Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Phase 1 · 40 location(s) · TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · NCT06625775Efficacy and Safety of Human Urinary Kallidinogenase Combined With Endovascular Therapy in Acute Ischemic Stroke With La
NA · 1 location(s) · Huashan Hospital · NCT06211712
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.